✦ LIBER ✦

The comparative effectiveness of methotrexate and anti-tumor necrosis factor therapy in psoriatic arthritis

✍ Scribed by Christopher T. Ritchlin

Book ID: 107554012
Publisher: Springer
Year: 2008
Tongue: English
Weight: 145 KB
Volume: 10
Category: Article
ISSN: 1523-3774
DOI: 10.1007/s11926-008-0047-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiangiogenic effects of anti–tumor nec

Antiangiogenic effects of anti–tumor necrosis factor α therapy with infliximab in psoriatic arthritis

✍ Juan D. Cañete; José L. Pablos; Raimon Sanmartí; Carmen Mallofré; Sara Marsal; J 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 1 views

## Abstract ## Objective Neovascularization, with an increased number of synovial vessels with a characteristic morphology, seems to contribute to the progression of psoriatic arthritis (PsA). Accordingly, angiogenesis may be an important therapeutic target in PsA. The aim of this study was to ana

Lymphoma in rheumatoid arthritis: The ef

Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti–tumor necrosis factor therapy in 18,572 patients

✍ Frederick Wolfe; Kaleb Michaud 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract ## Objective The risk of lymphoma is increased in patients with rheumatoid arthritis (RA), and spontaneous reporting suggests that methotrexate (MTX) and anti–tumor necrosis factor (anti‐TNF) therapy might be associated independently with an increased risk of lymphoma. However, data fr

Anti-tumor necrosis factor-α therapy and

Anti-tumor necrosis factor-α therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients

✍ Gianluigi Mazzoccoli; Incoronata Notarsanto; Gennaro Davide de Pinto; Mariangela 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 208 KB

Improvements in quality of life and func

Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti–tumor necrosis factor therapies

✍ Amr A. Saad; Darren M. Ashcroft; Kath D. Watson; Deborah P. M. Symmons; Peter R. 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 100 KB 👁 2 views

Erratum to: Anti-tumor necrosis factor-α

Erratum to: Anti-tumor necrosis factor-α therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients

✍ Gianluigi Mazzoccoli; Incoronata Notarsanto; Gennaro Davide de Pinto; Mariangela 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 92 KB

Anti–tumor necrosis factor therapy incre

Anti–tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis

✍ Anca Irinel Catrina; Erik af Klint; Sofia Ernestam; Sergiu-Bogdan Catrina; Dimit 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

## Abstract ## Objective Treatment of rheumatoid arthritis (RA) with tumor necrosis factor (TNF)–blocking agents, including etanercept and infliximab, has resulted in reductions in the radiographic progression of RA. However, the exact mechanism by which this protection occurs has not been determi